Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Prevention of Recurrent Wheeze in Children with LRTI
NCT07858773Phase 4Not yet recruiting
- Sponsor
- Norwegian University of Science and Technology
- Start
- Feb 2027
- Primary completion
- Jan 2029
- Countries
- 2
01
Overview
A Phase 4 trial of dexamethasone in wheeze, lower respiratory tract infection (LRTI), sponsored by Norwegian University of Science and Technology. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
wheezelower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT07858773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07858773.